HUT54298A - Process for producing pharmaceutical compositions containing p(2-)5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphtyl(-propenyl)-phenol active for the immunsysthem - Google Patents

Process for producing pharmaceutical compositions containing p(2-)5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphtyl(-propenyl)-phenol active for the immunsysthem Download PDF

Info

Publication number
HUT54298A
HUT54298A HU904053A HU405390A HUT54298A HU T54298 A HUT54298 A HU T54298A HU 904053 A HU904053 A HU 904053A HU 405390 A HU405390 A HU 405390A HU T54298 A HUT54298 A HU T54298A
Authority
HU
Hungary
Prior art keywords
tetrahydro
propenyl
compound
tetramethyl
immunsysthem
Prior art date
Application number
HU904053A
Other languages
German (de)
English (en)
Hungarian (hu)
Other versions
HU904053D0 (enExample
Inventor
Werner Bollag
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HU904053D0 publication Critical patent/HU904053D0/hu
Publication of HUT54298A publication Critical patent/HUT54298A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
HU904053A 1989-07-06 1990-07-02 Process for producing pharmaceutical compositions containing p(2-)5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphtyl(-propenyl)-phenol active for the immunsysthem HUT54298A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH252089 1989-07-06

Publications (2)

Publication Number Publication Date
HU904053D0 HU904053D0 (enExample) 1990-12-28
HUT54298A true HUT54298A (en) 1991-02-28

Family

ID=4235631

Family Applications (1)

Application Number Title Priority Date Filing Date
HU904053A HUT54298A (en) 1989-07-06 1990-07-02 Process for producing pharmaceutical compositions containing p(2-)5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphtyl(-propenyl)-phenol active for the immunsysthem

Country Status (9)

Country Link
EP (1) EP0407788A3 (enExample)
JP (1) JPH0344320A (enExample)
KR (1) KR910002434A (enExample)
AU (1) AU5861690A (enExample)
CA (1) CA2017956A1 (enExample)
HU (1) HUT54298A (enExample)
IE (1) IE902438A1 (enExample)
IL (1) IL94942A0 (enExample)
ZA (1) ZA905125B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60202500A (ja) * 1984-03-27 1985-10-12 松下電器産業株式会社 音素認識方法
ES2083891B1 (es) * 1991-04-24 1997-01-16 Univ Valencia Estudi General Procedimiento de obtencion de derivados del 2-(1-propenil) fenol.
DE69829966T2 (de) * 1997-05-14 2006-02-09 Atherogenics, Inc. Ein monoether von probucol und methoden zur hemmung der vcam-1 expression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3602473A1 (de) * 1986-01-28 1987-07-30 Basf Ag Vinylphenolderivate, ihre herstellung und verwendung
ZW6587A1 (en) * 1986-05-13 1987-12-02 Hoffmann La Roche Tetrahydro naphthanline derivatives

Also Published As

Publication number Publication date
AU5861690A (en) 1991-01-10
IL94942A0 (en) 1991-06-10
EP0407788A2 (de) 1991-01-16
HU904053D0 (enExample) 1990-12-28
JPH0344320A (ja) 1991-02-26
CA2017956A1 (en) 1991-01-06
IE902438A1 (en) 1991-06-19
ZA905125B (en) 1991-03-27
KR910002434A (ko) 1991-02-25
EP0407788A3 (en) 1991-05-15

Similar Documents

Publication Publication Date Title
US8383150B2 (en) Granulate formulation of pirfenidone and pharmaceutically acceptable excipients
US3337402A (en) Stable and palatable pharmaceutical composition
CN105753719B (zh) 一种盐酸曲恩汀化合物
JPS608000B2 (ja) アミノフエニル誘導体及び該誘導体を含有する生理活性剤
JPH0720966B2 (ja) 製薬学的に活性な化合物を含有する病気治療剤
WO2025167361A1 (zh) 6-((5,6-二苯基-1,2,4-三嗪-3-基)(异丙基)氨基)-n-(甲基磺酰基)己酰胺晶型a及其用途和制备方法
HUT54298A (en) Process for producing pharmaceutical compositions containing p(2-)5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphtyl(-propenyl)-phenol active for the immunsysthem
JPS60120995A (ja) 新規アミノ酸誘導体の製法
JPS6116399B2 (enExample)
JPS63264527A (ja) 抗エイズウイルス剤
JPH02250828A (ja) 新規免疫抑制剤
JP2017019751A (ja) ＩＦＮ−γ及び／又はＩＬ−１７の産生抑制剤、並びにＴｈ１細胞及び／又はＴｈ１７細胞の分化抑制剤
JP6085706B1 (ja) 抗トリトリコモナス剤
JPH07316051A (ja) 免疫抑制剤としてのベルベリン
JPS61145118A (ja) 免疫調節剤
WO2025002076A1 (zh) 一种mk2抑制剂在制备预防和/或治疗疾病药物中的应用
US3169908A (en) Therapeutic 3-(alpha, alpha, alpha-trifluoro-m-tolyloxy)-1, 2-propanediol-1-carbamate
RU2002738C1 (ru) Способ получени производных N-гидроксимочевин в виде R- или S-энантиомерных форм или их смеси, или их фармацевтически приемлемых солей с щелочным металлом
JP4945869B2 (ja) 免疫賦活剤
JPH04208271A (ja) インターフェロン産生促進剤
HK1007428A1 (en) (alfa-t-butyl aminomethyl-3,4-dichlorobenzyl) thioacetamide, process for its preparation and its applications
CN120789053A (zh) 化合物sp3在制备治疗心血管疾病的药物中的应用
JPH0717506B2 (ja) 免疫グロブリンｅに起因する疾患治療剤
JPS58208223A (ja) 抗腫瘍剤
CN1128949A (zh) 蛋白下垂诱导组合物

Legal Events

Date Code Title Description
DFC9 Refusal of application